Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synaptic Mechanisms of iTBS for MDD
NCT07593222Phase 2Recruiting
- Sponsor
- McLean Hospital
- Start
- Oct 2026
- Primary completion
- Dec 2030
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine, dextromethorphan in major depressive disorder (MDD), sponsored by McLean Hospital. Started Oct 2026; status: recruiting.
02
Drugs
d-cycloserinedextromethorphan
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07593222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07593222.